Seattle-based biotech startup Talus Bioscience landed $4.3 million in non-dilutive grants to boost development of its drug discovery platform that seeks compounds that affect gene activity. The startup received $2.3… Read More
A biotech startup born of an academic research project and inspired by emerging companies led by scientific founders is growing in Seattle. Talus Bioscience has raised $9.75 million in new… Read More